FAAH
Fatty-acid amide hydrolase 1
Also known as: FAAH-1, FAAH1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00519
- Gene
- FAAH
- Ensembl
- ENSG00000117480
- Chromosome
- 1
- Canonical length
- 579 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a protein that is responsible for the hydrolysis of a number of primary and secondary fatty acid amides, including the neuromodulatory compounds anandamide and oleamide. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
579 residues, UniProt reviewed canonical sequence.
>O00519|FAAH
1 MVQYELWAAL PGASGVALAC CFVAAAVALR WSGRRTARGA VVRARQRQRA GLENMDRAAQ
61 RFRLQNPDLD SEALLALPLP QLVQKLHSRE LAPEAVLFTY VGKAWEVNKG TNCVTSYLAD
121 CETQLSQAPR QGLLYGVPVS LKECFTYKGQ DSTLGLSLNE GVPAECDSVV VHVLKLQGAV
181 PFVHTNVPQS MFSYDCSNPL FGQTVNPWKS SKSPGGSSGG EGALIGSGGS PLGLGTDIGG
241 SIRFPSSFCG ICGLKPTGNR LSKSGLKGCV YGQEAVRLSV GPMARDVESL ALCLRALLCE
301 DMFRLDPTVP PLPFREEVYT SSQPLRVGYY ETDNYTMPSP AMRRAVLETK QSLEAAGHTL
361 VPFLPSNIPH ALETLSTGGL FSDGGHTFLQ NFKGDFVDPC LGDLVSILKL PQWLKGLLAF
421 LVKPLLPRLS AFLSNMKSRS AGKLWELQHE IEVYRKTVIA QWRALDLDVV LTPMLAPALD
481 LNAPGRATGA VSYTMLYNCL DFPAGVVPVT TVTAEDEAQM EHYRGYFGDI WDKMLQKGMK
541 KSVGLPVAVQ CVALPWQEEL CLRFMREVER LMTPEKQSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FAAH can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.21
- Highest tissue expression
- 46 nTPM
Expression across tissuesHPA
Tissue
- testis: 46 nTPM
- prostate: 45 nTPM
- choroid plexus: 44 nTPM
- spinal cord: 43 nTPM
- thyroid gland: 39 nTPM
- liver: 33 nTPM
Single-cell type
- late spermatids: 222 nCPM
- late primary spermatocytes: 157 nCPM
- enterocytes: 85 nCPM
- proximal tubule cells: 62 nCPM
- enteric transient amplifying cells: 60 nCPM
- oligodendrocytes: 55 nCPM
Immune cell
- eosinophil: 29 nTPM
- plasmacytoid DC: 8.8 nTPM
- myeloid DC: 8.2 nTPM
- classical monocyte: 6.9 nTPM
- intermediate monocyte: 1.9 nTPM
- total PBMC: 1.4 nTPM
Brain region
- white matter: 74 nTPM
- medulla oblongata: 48 nTPM
- choroid plexus: 43 nTPM
- pons: 41 nTPM
- cerebral cortex: 40 nTPM
- spinal cord: 40 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FAAH.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 101 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Polysubstance abuse, susceptibility to
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.05
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.64
- DepMap mean gene effect
- -0.21
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- arachidonate metabolic process
- fatty acid catabolic process
- monoacylglycerol catabolic process
- positive regulation of vasoconstriction
- regulation of trans-synaptic signaling by endocannabinoid, modulating synaptic transmission
Molecular functions
- amidase activity
- fatty acid amide hydrolase activity
- identical protein binding
- monoacylglycerol lipase activity
- phospholipid binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Amidase, conserved site
- Amidase signature domain
- Amidase signature (AS) superfamily
- Amidase
- Endocannabinoid-regulating amidase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FAAH as an antibody target. Whether an autoantibody or antibody against FAAH could matter depends on whether native FAAH is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FAAH is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FAAH as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...